| Mucosal injury during anti-cancer treatment: from pathobiology to bedside D Basile, P Di Nardo, C Corvaja, SK Garattini, G Pelizzari, C Lisanti, ... Cancers 11 (6), 857, 2019 | 113 | 2019 |
| Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time? G Buono, L Gerratana, M Bulfoni, N Provinciali, D Basile, M Giuliano, ... Cancer Treatment Reviews 73, 73-83, 2019 | 104 | 2019 |
| Sarcopenia: looking to muscle mass to better manage pancreatic cancer patients D Basile, C Corvaja, R Caccialanza, G Aprile Current Opinion in Supportive and Palliative Care 13 (4), 279-285, 2019 | 30 | 2019 |
| The MIMIC study: prognostic role and cutoff definition of monocyte‐to‐lymphocyte ratio and lactate dehydrogenase levels in metastatic colorectal cancer D Basile, SK Garattini, C Corvaja, M Montico, F Cortiula, G Pelizzari, ... The oncologist 25 (8), 661-668, 2020 | 27 | 2020 |
| The use of liquid biopsy in early breast cancer: Clinical evidence and future perspectives P D’Amico, C Corvaja, L Gerratana, C Reduzzi, G Curigliano, ... J. Cancer Metastasis Treat 7 (3), 2021 | 18 | 2021 |
| Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer L Gerratana, D Basile, A Franzoni, L Allegri, D Viotto, C Corvaja, L Bortot, ... Frontiers in oncology 10, 550185, 2020 | 18 | 2020 |
| First-and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: a real-world study D Basile, L Gerratana, C Corvaja, G Pelizzari, G Franceschin, E Bertoli, ... The Breast 57, 104-112, 2021 | 17 | 2021 |
| Targeting HER3 for cancer treatment: a new horizon for an old target J Uliano, C Corvaja, G Curigliano, P Tarantino ESMO open 8 (1), 100790, 2023 | 16 | 2023 |
| Immunotherapy in NSCLC patients with brain metastases S Buriolla, G Pelizzari, C Corvaja, M Alberti, G Targato, M Bortolot, ... International Journal of Molecular Sciences 23 (13), 7068, 2022 | 15 | 2022 |
| Emerging role of genomics and cell-free DNA in breast cancer L Gerratana, AA Davis, AN Shah, C Lin, C Corvaja, M Cristofanilli Current treatment options in oncology 20, 1-15, 2019 | 13 | 2019 |
| Drug holidays and overall survival of patients with metastatic colorectal cancer SK Garattini, D Basile, M Bonotto, E Ongaro, L Porcu, C Corvaja, ... Cancers 13 (14), 3504, 2021 | 9 | 2021 |
| A multi-center, real-life experience on liquid biopsy practice for EGFR testing in Non-Small Cell Lung Cancer (NSCLC) patients F Cortiula, G Pasello, A Follador, G Nardo, V Polo, E Scquizzato, ... Diagnostics 10 (10), 765, 2020 | 6 | 2020 |
| Immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: A systematic review I Attili, A Passaro, C Corvaja, PT Aliaga, E Del Signore, G Spitaleri, ... Cancer Treatment Reviews, 102602, 2023 | 4 | 2023 |
| The SAFFO Study: sex-related prognostic role and cut-off definition of monocyte-to-lymphocyte ratio (mlr) in metastatic colorectal cancer C Lisanti, D Basile, SK Garattini, A Parnofiello, C Corvaja, F Cortiula, ... Cancers 15 (1), 175, 2022 | 3 | 2022 |
| Combination immunotherapy strategies for triple-negative breast cancer: current progress and barriers within the pharmacological landscape J Uliano, E Nicolò, C Corvaja, B Taurelli Salimbeni, D Trapani, ... Expert Review of Clinical Pharmacology 15 (12), 1399-1413, 2022 | 3 | 2022 |
| MET in Non-Small-Cell Lung Cancer (NSCLC): Cross ‘a Long and Winding Road’Looking for a Target G Spitaleri, P Trillo Aliaga, I Attili, E Del Signore, C Corvaja, C Corti, ... Cancers 15 (19), 4779, 2023 | 2 | 2023 |
| Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running? G Spitaleri, P Trillo Aliaga, I Attili, E Del Signore, C Corvaja, C Corti, ... Current Oncology 30 (5), 5072-5092, 2023 | 2 | 2023 |
| Detection of SARS-CoV-2 infection prevalence in 860 cancer patients with a combined screening procedure including triage, molecular nasopharyngeal swabs and rapid serological … A Candoni, G Petruzzellis, A Sperotto, V Andreotti, M Giavarra, C Corvaja, ... PloS one 17 (2), e0262784, 2022 | 2 | 2022 |
| Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer SK Garattini, M Bonotto, L Porcu, E Ongaro, L Gerratana, D Basile, ... Future Oncology 16 (32), 2645-2660, 2020 | 2 | 2020 |
| 1741P Triage procedures for COVID-19 in an Italian cancer centre G Targato, D Zara, R Fioraso, L Bortot, G Pelizzari, C Corvaja, L Palmero, ... Annals of Oncology 31, S1018, 2020 | 2 | 2020 |
